Advances in human genetic and plant biotechnology are transforming medicine. Plant-based production of valuable Active Pharmaceutical Ingredients (API) such as proteins and phytochemicals can lead the way to new drugs without the ethical and technical drawbacks of mammalian transgenic production, or the inherent limitations of yeast-based fermentation systems.
SubTerra has proven its plant-based API production methods in research and several contract growing projects, scaling up production from multiple input streams, including transgenic seed, plantlets, and line continuation through cloning.
Copyright 2022 SubTerra LLC
Permission, reproduction or distribution without express written permission of SubTerra LLC is prohibited.
